RPX-0101034

N/A

Report date: 2023/04/14 10:52:06
NME

Base Information

Drug NameRPX-0101034
Drug Alias NameRPX-0101034
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-ketoglutarate-dependent dioxygenase FTO inhibitors
TargetsAlpha-ketoglutarate-dependent dioxygenase FTO
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaDiscontinued
Originator CompaniesRuipuxin(Suzhou)Bio-Medical Technology Co LtdNational Institute Of Biological Sciences, Beijing
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Biological Sciences, BeijingRuipuxin(Suzhou)Bio-Medical Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A